XML 51 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated statements of comprehensive income - EUR (€)
€ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of comprehensive income [abstract]      
Net income € 5,436 € 8,484 € 6,279
Attributable to equity holders of Sanofi 5,400 8,371 6,223
Attributable to non-controlling interests 36 113 56
Other comprehensive income:      
Actuarial gains/(losses) (171) 654 686
Change in fair value of equity instruments included in financial assets and financial liabilities 97 13 165
Tax effects (3) (216) (54)
Items not subsequently reclassifiable to profit or loss (77) 451 797
Change in fair value of debt instruments included in financial assets 21 (77) (21)
Change in fair value of cash flow hedges (1) 7 (6)
Change in currency translation differences (1,540) 2,278 2,459
Tax effects (6) 105 78
Items subsequently reclassifiable to profit or loss (1,526) 2,313 2,510
Other comprehensive income for the period, net of taxes (1,603) 2,764 3,307
Comprehensive income 3,833 11,248 9,586
Attributable to equity holders of Sanofi 3,810 11,130 9,519
Attributable to non-controlling interests € 23 € 118 € 67